EA
AZN icon

Emerald Acquisition’s AstraZeneca AZN Stock Holding History

Emerald Acquisition’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.93M Sell
29,297
-12,978
-31% -$848K ﹤0.01% 1778
2016
Q2 		$2.55M Buy
+42,275
New +$2.46M ﹤0.01% 1709

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Emerald Acquisition's AZN Position: Q3 2016 in Review

Emerald Acquisition reduced its AstraZeneca (AZN) stake by 31% in Q3 2016, selling an estimated $848K and leaving 29,297 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Emerald Acquisition first reported a position in AZN in Q2 2016 and has held it in 2 quarters since. The position peaked at $2.55M in Q2 2016. 449 funds tracked by Wall St. Rank hold AZN as of Q3 2016.

  • Emerald Acquisition held 29,297 shares of AstraZeneca worth $1.93M as of Q3 2016.
  • Emerald Acquisition sold 12,978 AstraZeneca shares in Q3 2016, an estimated $848K.
  • AstraZeneca made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1778 holding.
  • Emerald Acquisition first reported a position in AstraZeneca in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's AstraZeneca position peaked at $2.55M in Q2 2016.
  • 449 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.